Correlation Between DiaMedica Therapeutics and Akebia Ther

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Akebia Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Akebia Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Akebia Ther, you can compare the effects of market volatilities on DiaMedica Therapeutics and Akebia Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Akebia Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Akebia Ther.

Diversification Opportunities for DiaMedica Therapeutics and Akebia Ther

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between DiaMedica and Akebia is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Akebia Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Ther and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Akebia Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Ther has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Akebia Ther go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Akebia Ther

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.34 times less return on investment than Akebia Ther. But when comparing it to its historical volatility, DiaMedica Therapeutics is 1.32 times less risky than Akebia Ther. It trades about 0.08 of its potential returns per unit of risk. Akebia Ther is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  42.00  in Akebia Ther on September 3, 2024 and sell it today you would earn a total of  164.00  from holding Akebia Ther or generate 390.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

DiaMedica Therapeutics  vs.  Akebia Ther

 Performance 
       Timeline  
DiaMedica Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Akebia Ther 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Akebia Ther are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady fundamental drivers, Akebia Ther sustained solid returns over the last few months and may actually be approaching a breakup point.

DiaMedica Therapeutics and Akebia Ther Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DiaMedica Therapeutics and Akebia Ther

The main advantage of trading using opposite DiaMedica Therapeutics and Akebia Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Akebia Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will offset losses from the drop in Akebia Ther's long position.
The idea behind DiaMedica Therapeutics and Akebia Ther pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing